Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4710 -0.0080 (-1.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share May 15, 2023 Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023. Via Benzinga Enveric Biosciences Reports First Quarter 2023 Financial Results and Operational Highlights May 15, 2023 From Enveric Biosciences, Inc. Via Business Wire Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month May 02, 2023 From Enveric Biosciences, Inc. Via Business Wire EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits April 20, 2023 Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine. Via Benzinga EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key' April 14, 2023 Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental... Via Benzinga Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference April 10, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results April 03, 2023 From Enveric Biosciences, Inc. Via Business Wire What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry April 03, 2023 The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. Via Benzinga Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Via Benzinga Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373 March 23, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications March 21, 2023 From Enveric Biosciences Via Business Wire Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program March 21, 2023 Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics... Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme March 14, 2023 Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a... Via Benzinga Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery March 14, 2023 From Enveric Biosciences Via Business Wire Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More March 13, 2023 Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial Via Benzinga Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person March 08, 2023 This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established... Via Benzinga Here Are The Year's Highest Priced Psychedelics Stocks In US Markets March 06, 2023 After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on. Via Benzinga Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) February 28, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) February 23, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference February 22, 2023 From Enveric Biosciences Via Business Wire The 7 Most Promising Psychedelic Stocks to Buy in February February 05, 2023 These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. Via InvestorPlace Enveric Biosciences to Present at the BIO CEO & Investor Conference February 01, 2023 From Enveric Biosciences Via Business Wire What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways January 03, 2023 What a year for psychedelics! Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session December 21, 2022 Via Benzinga Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023" December 21, 2022 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session December 08, 2022 Via Benzinga Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders November 28, 2022 From Enveric Biosciences Via Business Wire Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference November 16, 2022 From Enveric Biosciences Via Business Wire Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022 November 01, 2022 From Enveric Biosciences Via Business Wire < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.